Friday, March 27, 2015 11:00:09 AM
Recent ESPR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 08:08:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/17/2024 07:25:29 PM
- Esperion EU Partner Reports Final Real-World Results from MILOS German Cohort Demonstrating Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid • GlobeNewswire Inc. • 10/02/2024 12:00:00 PM
- Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/25/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:12:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:11:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:02:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 07:28:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 07:20:06 PM
- Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:03:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/19/2024 07:50:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/12/2024 08:33:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:08:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:21:11 AM
- Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/12/2024 10:00:00 AM
- U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb • IH Market News • 08/12/2024 09:47:41 AM
- Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/07/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:34:24 PM
- Esperion to Report Second Quarter 2024 Financial Results on August 12 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Esperion to Participate in Upcoming BTIG Biotech Conference • GlobeNewswire Inc. • 07/24/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 12:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 12:29:55 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM